Postoperative adjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of hepatocellular carcinoma patients with microvascular invasion: A preliminary report of a phase III, randomized, controlled clinical trial.

Shaohua Li,Wei Wei,Qiaoxuan Wang,Zhixing Guo,Jie Mei,Lianghe Lu,Yihong Ling,Li Xu,Min Shan Chen,Wenping Lin,Jingwen Zou,Yuhua Wen,Rong Ping Guo

Postoperative adjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of hepatocellular carcinoma patients with microvascular invasion: A preliminary report of a phase III, randomized, controlled clinical trial.

2020

Shaohua Li
Wei Wei
Qiaoxuan Wang
Zhixing Guo
Jie Mei
Lianghe Lu
Yihong Ling
Li Xu
Min Shan Chen
Wenping Lin
Jingwen Zou
Yuhua Wen
Rong Ping Guo

527Background: Microvascular invasion (MVI) is a risk factor for recurrence after hepatectomy for hepatocellular carcinoma (HCC) patients. This study aimed to investigate to efficacy and safety of ...

Keywords:

Hepatocellular carcinoma
FOLFOX
Internal medicine
Clinical trial
Oncology
Chemotherapy
Adjuvant
Medicine
Pathology
infusion chemotherapy
Risk factor
preliminary report
Hepatectomy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations